Albert B. Sabin Vaccine Institute   Report issue

Academic/Hospital Phase 1 Phase 3
Founded: Washington D.C. United States (1993)

Organization Overview

First Clinical Trial
2006
NCT00713726
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Albert B. Sabin Vaccine Institute | The Albert B. Sabin Vaccine Institute